These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7741897)

  • 21. Why patients with Alzheimer's disease may show increased sensitivity to tropicamide eye drops: role of locus coeruleus.
    Hou RH; Samuels ER; Raisi M; Langley RW; Szabadi E; Bradshaw CM
    Psychopharmacology (Berl); 2006 Jan; 184(1):95-106. PubMed ID: 16308726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased mydriatic response to tropicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's dementia.
    Kálmán J; Kanka A; Maglóczky E; Szóke A; Járdánházy T; Janka Z
    Biol Psychiatry; 1997 Apr; 41(8):909-11. PubMed ID: 9099419
    [No Abstract]   [Full Text] [Related]  

  • 23. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?
    Litvan I; FitzGibbon EJ
    Neurology; 1996 Nov; 47(5):1324-6. PubMed ID: 8909451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detecting Alzheimer's disease.
    Pomara N; Sitaram N
    Science; 1995 Mar; 267(5204):1579-80; author reply 1580-1. PubMed ID: 7886438
    [No Abstract]   [Full Text] [Related]  

  • 25. Detecting Alzheimer's disease.
    Katz B
    Science; 1995 Mar; 267(5204):1578-79; author reply 1580-1. PubMed ID: 7886437
    [No Abstract]   [Full Text] [Related]  

  • 26. Cholinergic dysfunction in cognitive impairments after aneurysmal subarachnoid hemorrhage.
    Nozaki T; Sakai N; Oishi H; Nishizawa S; Namba H
    Neurosurgery; 2002 Oct; 51(4):944-7; discussion 947-8. PubMed ID: 12234401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholinergic supersensitivity of the iris in Alzheimer's disease.
    Idiaquez J; Alvarez G; Villagra R; San Martin RA
    J Neurol Neurosurg Psychiatry; 1994 Dec; 57(12):1544-5. PubMed ID: 7798991
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide.
    Eyeson-Annan ML; Hirst LW; Battistutta D; Green A
    Ophthalmology; 1998 Apr; 105(4):726-32. PubMed ID: 9544648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced miotic response to topical dilute pilocarpine in patients with Alzheimer's disease.
    Kaneyuki H; Mitsuno S; Nishida T; Yamada M
    Neurology; 1998 Mar; 50(3):802-4. PubMed ID: 9521282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The eyes don't have it in Alzheimer's disease.
    Newman NJ
    Mayo Clin Proc; 1997 Jun; 72(6):581-2. PubMed ID: 9179146
    [No Abstract]   [Full Text] [Related]  

  • 31. [The eyes and Alzheimer's disease].
    Gorman C
    Servir; 1994; 42(6):335. PubMed ID: 7732399
    [No Abstract]   [Full Text] [Related]  

  • 32. Pupil dilatation with tropicamide. The effects on acuity, accommodation and refraction.
    Montgomery DM; MacEwan CJ
    Eye (Lond); 1989; 3 ( Pt 6)():845-8. PubMed ID: 2630368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pupil response to tropicamide following corneal crosslinking.
    Kymionis GD; Paraskevopoulos TA; Liakopoulos DA; Grentzelos MA; Kouroupaki AI; Tsoulnaras KI; Panagopoulou SI; Mazzotta C; Detorakis ET
    Eur J Ophthalmol; 2016 Aug; 26(5):394-7. PubMed ID: 26833233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single dose of 1% tropicamide and 10% phenylephrine for pupil dilation.
    Ratanapakorn T; Yospaiboon Y; Chaisrisawadsuk N
    J Med Assoc Thai; 2006 Nov; 89(11):1934-9. PubMed ID: 17205877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.
    Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):281-9. PubMed ID: 12506086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced mydriasis from repeated doses of tropicamide and cyclopentolate.
    McCormack DL
    Ophthalmic Surg; 1990 Jul; 21(7):508-12. PubMed ID: 2399002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tropicamide 1% mydriatic effect: comparison between spray in closed eyes and eye drops in open eyes.
    Portes AJ; Barbosa AC; de Mello GL; Lopes MA; Cavalcanti RS
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):632-5. PubMed ID: 22775152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The pupillary response test as a method to differentiate various types of dementia].
    Grünberger J; Prause W; Frottier P; Stöhr H; Saletu B; Haushofer M; Rainer M
    Neuropsychiatr; 2009; 23(1):52-7. PubMed ID: 19272292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pupil response to tropicamide following laser in situ keratomileusis.
    Chung HS; Feder RS
    J Cataract Refract Surg; 2005 Mar; 31(3):553-6. PubMed ID: 15811744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone.
    Lux AL; Degoumois A; Barjol A; Mouriaux F; Denion E
    Acta Ophthalmol; 2017 Mar; 95(2):165-169. PubMed ID: 27519933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.